197 related articles for article (PubMed ID: 17926121)
1. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
Xia CF; Zhang Y; Zhang Y; Boado RJ; Pardridge WM
Pharm Res; 2007 Dec; 24(12):2309-16. PubMed ID: 17926121
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology.
Xia CF; Boado RJ; Pardridge WM
Mol Pharm; 2009; 6(3):747-51. PubMed ID: 19093871
[TBL] [Abstract][Full Text] [Related]
3. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
Zhang Y; Boado RJ; Pardridge WM
J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
[TBL] [Abstract][Full Text] [Related]
4. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
5. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
6. shRNA and siRNA delivery to the brain.
Pardridge WM
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):141-52. PubMed ID: 17434235
[TBL] [Abstract][Full Text] [Related]
7. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
Yoshikawa T; Pardridge WM
J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
[TBL] [Abstract][Full Text] [Related]
8. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
Deguchi Y; Kurihara A; Pardridge WM
Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
[TBL] [Abstract][Full Text] [Related]
9. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
Kang YS; Pardridge WM
J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
Kurihara A; Deguchi Y; Pardridge WM
Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
12. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
13. Antisense imaging of gene expression in the brain in vivo.
Shi N; Boado RJ; Pardridge WM
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14709-14. PubMed ID: 11106372
[TBL] [Abstract][Full Text] [Related]
14. Intravenous, non-viral RNAi gene therapy of brain cancer.
Pardridge WM
Expert Opin Biol Ther; 2004 Jul; 4(7):1103-13. PubMed ID: 15268677
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein.
Li JY; Sugimura K; Boado RJ; Lee HJ; Zhang C; Duebel S; Pardridge WM
Protein Eng; 1999 Sep; 12(9):787-96. PubMed ID: 10506289
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
[TBL] [Abstract][Full Text] [Related]
17. Further studies on targeted DNA transfer to cells using a highly efficient delivery system of biotinylated transferrin and biotinylated polylysine complexed to streptavidin.
Schoeman R; Joubert D; Ariatti M; Hawtrey AO
J Drug Target; 1995; 2(6):509-16. PubMed ID: 7773613
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
Kang YS; Bickel U; Pardridge WM
Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
[TBL] [Abstract][Full Text] [Related]
19. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
Morizono K; Xie Y; Helguera G; Daniels TR; Lane TF; Penichet ML; Chen IS
J Gene Med; 2009 Aug; 11(8):655-63. PubMed ID: 19455593
[TBL] [Abstract][Full Text] [Related]
20. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
